Attached files
| file | filename |
|---|---|
| 10-K - Statera Biopharma, Inc. | v177770_10k.htm |
| EX-3.1 - Statera Biopharma, Inc. | v177770_ex3-1.htm |
| EX-31.2 - Statera Biopharma, Inc. | v177770_ex31-2.htm |
| EX-31.1 - Statera Biopharma, Inc. | v177770_ex31-1.htm |
| EX-23.1 - Statera Biopharma, Inc. | v177770_ex23-1.htm |
Exhibit
32.1
Certification*
In
connection with the Annual Report of Cleveland BioLabs, Inc., (the “Company”),
on Form 10-K for the fiscal year ending December 31, 2009 as filed with the
Securities and Exchange Commission on the date hereof (the “Annual Report”)
pursuant to the requirement set forth in Rule 13a-14(b) of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of
Chapter 63 of Title 18 of the United States Code (18 U.S.C.§ 1350), Michael
Fonstein, Chief Executive Officer of the Company, and John A. Marhofer, Jr.,
Chief Financial Officer of the Company, each hereby certifies that, to the best
of his knowledge:
1. The Annual Report fully
complies with the requirements of Section 13(a) or Section 15(d) of the Exchange
Act, and
2. The information
contained in the Annual Report fairly presents, in all material respects, the
financial condition and results of operations of the Company for the period
covered by the Annual Report.
|
Dated:
March 22, 2010
|
By:
|
/s/
Michael Fonstein
|
|
|
Michael
Fonstein
|
|||
| Chief Executive Officer | |||
| (Principal Executive Officer) | |||
|
Dated:
March 22, 2010
|
By:
|
/s/
John A. Marhofer, Jr.
|
|
|
John
A. Marhofer, Jr.
|
|||
|
Chief
Financial Officer
|
|||
|
(Principal
Financial and Accounting Officer)
|
|||
|
*
|
This
certification accompanies the Annual Report to which it relates, is not
deemed filed with the Securities and Exchange Commission and is not to be
incorporated by reference into any filing of Cleveland BioLabs, Inc. under
the Securities Act of 1933, as amended, or the Securities Exchange Act of
1934, as amended (whether made before or after the date of the Annual
Report), irrespective of any general incorporation language contained in
such filing.
|